KRISTEN GIACOMIN: Open Payments
NPI 1952950560 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 52 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $1,260
Food & beverage: $1,183Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $291 |
| Janssen Biotech, Inc. | 6 | $180 |
| GENZYME CORPORATION | 4 | $143 |
| E.R. Squibb & Sons, L.L.C. | 5 | $141 |
| UCB, Inc. | 4 | $93 |
| Amgen Inc. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| Sandoz Inc. | 1 | $33 |
Products named: RINVOQ, TREMFYA, KEVZARA, ORENCIA, Bimzelx, SKYRIZI, KRYSTEXXA, EUFLEXXA.
Industry payments across IN — which companies pay providers there.
